Onset dynamics of ventricular tachyarrhythmias as measured by dominant frequency

A novel algorithm for ventricular arrhythmia classification using a fuzzy logic approach

In the present study, it has been shown that an unnecessary implantable cardioverter-defibrillator (ICD) shock is often delivered to patients with an ambiguous ECG rhythm in the overlap zone between ventricular tachycardia (VT) and ventricular fibrillation (VF); these shocks significantly increase mortality. Therefore, accurate classification of the arrhythmia into VT, organized VF (OVF) or disorganized VF (DVF) is crucial to assist ICDs to deliver appropriate therapy. A classification algorithm using a fuzzy logic classifier was developed for accurately classifying the arrhythmias into VT, OVF or DVF. Compared with other studies, our method aims to combine ten ECG detectors that are calculated in the time domain and the frequency domain in addition to different levels of complexity for detecting subtle structure differences between VT, OVF and DVF. The classification in the overlap zone between VT and VF is refined by this study to avoid ambiguous identification. The present method was trained and tested using public ECG signal databases. A two-level classification was performed to first detect VT with an accuracy of 92.6 %, and then the discrimination between OVF and DVF was detected with an accuracy of 84.5 %. The validation results indicate that the proposed method has superior performance in identifying the organization level between the three types of arrhythmias (VT, OVF and DVF) and is promising for improving the appropriate therapy choice and decreasing the possibility of sudden cardiac death.

Discriminative sparse coding of ECG during ventricular arrhythmias using LC-K-SVD approach

Ventricular tachycardia (VT) and ventricular fibrillation (VF) are two major types of ventricular arrhythmias that results due to abnormalities in the electrical activation in the ventricles of the heart. VF is the lethal of the two arrhythmias, which may lead to sudden cardiac death. The treatment options for the two arrhythmias are different. Therefore, detection and characterization of the two arrhythmias is critical to choose appropriate therapy options. Due to the time-varying nature of the signal content during cardiac arrhythmias, modeling and extracting information from them using time and frequency localized functions would be ideal. To this effect, in this work, we perform discriminative sparse coding of the ECG during ventricular arrhythmia with hybrid time-frequency dictionaries using the recently introduced Label consistent K-SVD (LC-K-SVD) approach. Using 944 segments of ventricular arrhythmias extracted from 23 patients in the Malignant Ventricular Ectopy and Creighton University Tachy-Arrhythmia databases, an overall classification accuracy of 71.55% was attained with a hybrid dictionary of Gabor and symlet4 atoms. In comparison, for the same database and non-trained dictionary (i.e the original dictionary) the classification accuracy was found to be 62.71%. In addition, the modeling error using the trained dictionary from LC-K-SVD approach was found to be significantly lower to the one using the non-trained dictionary.

Optimization of novel spectral estimator for fractionated electrogram analysis is helpful to discern atrial fibrillation type

INTRODUCTION

Paroxysmal versus persistent atrial fibrillation (AF) can be distinguished based on differences in the spectral parameters of fractionated atrial electrograms. Maximization of these differences would improve characterization of the arrhythmogenic substrate. A novel spectral estimator (NSE) has been shown previously to provide greater distinction in AF spectral parameters as compared with the Fourier transform estimator. Herein, it is described how the differences in NSE spectral parameters can be further improved.

METHOD

In 10 persistent and 9 paroxysmal AF patients undergoing electrophysiologic study, fractionated electrograms were acquired from the distal bipolar ablation electrode. A total of 204 electrograms were recorded from the pulmonary vein (PV) antra and from the anterior and posterior left atrial free wall. The following spectral parameters were measured: the dominant frequency (DF), which reflects local activation rate, the DF amplitude (DA), and the mean spectral profile (MP), which represents background electrical activity. To optimize differences in parameters between paroxysmal versus persistent AF patients, the NSE was varied by selectively removing subharmonics, using a threshold. The threshold was altered in steps to determine the optimal subharmonics removal.

RESULTS

At the optimal threshold level, mean differences in persistent versus paroxysmal AF spectral parameters were: ΔDA=+0.371 mV, ΔDF=+0.737 Hz, and ΔMP=-0.096 mV. When subharmonics were not removed, the differences were substantially less: ΔDA=+0.301 mV, ΔDF=+0.699 Hz, and ΔMP=-0.063 mV.

CONCLUSIONS

NSE optimization produces greater spectral parameter difference between persistent versus paroxysmal AF data. Quantifying spectral parameter differences can be assistive in characterizing the arrhythmogenic substrate.

Computational method for high resolution spectral analysis of fractionated atrial electrograms

BACKGROUND

The discrete Fourier transform (DFT) is often used as a spectral estimator for analysis of complex fractionated atrial electrograms (CFAE) acquired during atrial fibrillation (AF). However, time resolution can be unsatisfactory, as the frequency resolution is proportional to rate/time interval. In this study we compared the DFT to a new spectral estimator with improved time-frequency resolution.

METHOD

Recently, a novel spectral estimator (NSE) based upon signal averaging was derived and implemented computationally. The NSE is similar to the DFT in that both estimators model the autocorrelation function to form the power spectrum. However, as derived in this study, NSE frequency resolution is proportional to rate/period(2) and thus unlike the DFT, is not directly dependent on the window length. We hypothesized that the NSE would provide improved time resolution while maintaining satisfactory frequency resolution for computation of CFAE spectral parameters. Window lengths of 8s, 4s, 2s, 1s, and 0.5s were used for analysis. Two criteria gauged estimator performance. Firstly, a periodic electrogram pattern with phase jitter was embedded in interference. The error in detecting the frequency of the periodic pattern was determined. Secondly, significant differences in spectral parameters for paroxysmal versus persistent AF data, which have known dissimilarities, were determined using the DFT versus NSE methods. The parameters measured were the dominant amplitude, dominant frequency, and mean spectral profile.

RESULTS

At all time resolutions, the error in detecting the frequency of the repeating electrogram pattern was less for NSE than for DFT (p<0.001). The DFT was accurate to 2s time resolution/0.5 Hz frequency resolution, while the NSE was accurate to 0.5s time resolution/0.05 Hz frequency resolution. At all time resolutions, significant differences in the dominant amplitude spectral parameter for paroxysmal versus persistent CFAE were greater using NSE than DFT (p<0.0001). For three of five time resolutions, the NSE had greater significant differences than DFT for discriminating the dominant frequency and mean spectral profile parameters between AF types.

CONCLUSIONS

The results suggest that the NSE has improved performance versus DFT for measurement of CFAE spectral properties.

Comparison of spectral estimators for characterizing fractionated atrial electrograms

Background

Complex fractionated atrial electrograms (CFAE) acquired during atrial fibrillation (AF) are commonly assessed using the discrete Fourier transform (DFT), but this can lead to inaccuracy. In this study, spectral estimators derived by averaging the autocorrelation function at lags were compared to the DFT.

Method

Bipolar CFAE of at least 16 s duration were obtained from pulmonary vein ostia and left atrial free wall sites (9 paroxysmal and 10 persistent AF patients). Power spectra were computed using the DFT and three other methods: 1. a novel spectral estimator based on signal averaging (NSE), 2. the NSE with harmonic removal (NSH), and 3. the autocorrelation function average at lags (AFA). Three spectral parameters were calculated: 1. the largest fundamental spectral peak, known as the dominant frequency (DF), 2. the DF amplitude (DA), and 3. the mean spectral profile (MP), which quantifies noise floor level. For each spectral estimator and parameter, the significance of the difference between paroxysmal and persistent AF was determined.

Results

For all estimators, mean DA and mean DF values were higher in persistent AF, while the mean MP value was higher in paroxysmal AF. The differences in means between paroxysmals and persistents were highly significant for 3/3 NSE and NSH measurements and for 2/3 DFT and AFA measurements (p<0.001). For all estimators, the standard deviation in DA and MP values were higher in persistent AF, while the standard deviation in DF value was higher in paroxysmal AF. Differences in standard deviations between paroxysmals and persistents were highly significant in 2/3 NSE and NSH measurements, in 1/3 AFA measurements, and in 0/3 DFT measurements.

Conclusions

Measurements made from all four spectral estimators were in agreement as to whether the means and standard deviations in three spectral parameters were greater in CFAEs acquired from paroxysmal or in persistent AF patients. Since the measurements were consistent, use of two or more of these estimators for power spectral analysis can be assistive to evaluate CFAE more objectively and accurately, which may lead to improved clinical outcome. Since the most significant differences overall were achieved using the NSE and NSH estimators, parameters measured from their spectra will likely be the most useful for detecting and discerning electrophysiologic differences in the AF substrate based upon frequency analysis of CFAE.

Identification of recurring patterns in fractionated atrial electrograms using new transform coefficients

Background

Identification of recurrent patterns in complex fractionated atrial electrograms (CFAE) has been used to differentiate paroxysmal from persistent atrial fibrillation (AF). Detection of the atrial CFAE patterns might therefore be assistive in guiding radiofrequency catheter ablation to drivers of the arrhythmia. In this study a technique for robust detection and classification of recurrent CFAE patterns is described.

Method

CFAE were obtained from the four pulmonary vein ostia, and from the anterior and posterior left atrium, in 10 patients with paroxysmal AF and 10 patients with longstanding persistent AF (216 recordings in total). Sequences 8.4 s in length were analyzed (8,192 sample points, 977 Hz sampling). Among the 216 sequences, two recurrent patterns A and B were substituted for 4 and 5 of the sequences, respectively. To this data, random interference, and random interference + noise were separately added. Basis vectors were constructed using a new transform that is derived from ensemble averaging. Patterns A and B were then detected and classified using a threshold level of Euclidean distance between spectral signatures as constructed with transform coefficients.

Results

In the presence of interference, sensitivity to detect and distinguish two patterns A and B was 96.2%, while specificity to exclude nonpatterns was 98.0%. In the presence of interference + noise, sensitivity was 89.1% while specificity was 97.0%.

Conclusions

Transform coefficients computed from ensemble averages can be used to succinctly quantify synchronized patterns present in AF data. The technique is useful to automatically detect recurrent patterns in CFAE that are embedded in interference without user bias. This quantitation can be implemented in real-time to map the AF substrate prior to and during catheter ablation.

A new transform for the analysis of complex fractionated atrial electrograms

BACKGROUND

Representation of independent biophysical sources using Fourier analysis can be inefficient because the basis is sinusoidal and general. When complex fractionated atrial electrograms (CFAE) are acquired during atrial fibrillation (AF), the electrogram morphology depends on the mix of distinct nonsinusoidal generators. Identification of these generators using efficient methods of representation and comparison would be useful for targeting catheter ablation sites to prevent arrhythmia reinduction.

METHOD

A data-driven basis and transform is described which utilizes the ensemble average of signal segments to identify and distinguish CFAE morphologic components and frequencies. Calculation of the dominant frequency (DF) of actual CFAE, and identification of simulated independent generator frequencies and morphologies embedded in CFAE, is done using a total of 216 recordings from 10 paroxysmal and 10 persistent AF patients. The transform is tested versus Fourier analysis to detect spectral components in the presence of phase noise and interference. Correspondence is shown between ensemble basis vectors of highest power and corresponding synthetic drivers embedded in CFAE.

RESULTS

The ensemble basis is orthogonal, and efficient for representation of CFAE components as compared with Fourier analysis (p ≤ 0.002). When three synthetic drivers with additive phase noise and interference were decomposed, the top three peaks in the ensemble power spectrum corresponded to the driver frequencies more closely as compared with top Fourier power spectrum peaks (p ≤ 0.005). The synthesized drivers with phase noise and interference were extractable from their corresponding ensemble basis with a mean error of less than 10%.

CONCLUSIONS

The new transform is able to efficiently identify CFAE features using DF calculation and by discerning morphologic differences. Unlike the Fourier transform method, it does not distort CFAE signals prior to analysis, and is relatively robust to jitter in periodic events. Thus the ensemble method can provide a useful alternative for quantitative characterization of CFAE during clinical study.